VX18-445-110


Study Name Study Title Study Type Sponsor Sponsor Type
VX18-445-110 A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes). Clinical Trial Vertex Industry Sponsored